WO1987007645A1 - A method of sequencing nucleic acids - Google Patents

A method of sequencing nucleic acids Download PDF

Info

Publication number
WO1987007645A1
WO1987007645A1 PCT/GB1987/000384 GB8700384W WO8707645A1 WO 1987007645 A1 WO1987007645 A1 WO 1987007645A1 GB 8700384 W GB8700384 W GB 8700384W WO 8707645 A1 WO8707645 A1 WO 8707645A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
membrane
nucleic acids
sequencing
added
Prior art date
Application number
PCT/GB1987/000384
Other languages
French (fr)
Inventor
Anthony Robert Milnes Coates
Lucinda Mary Clare Hall
Ian Blench
Original Assignee
The London Hospital Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The London Hospital Medical College filed Critical The London Hospital Medical College
Publication of WO1987007645A1 publication Critical patent/WO1987007645A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation

Abstract

A method of sequencing nucleic acids, such as DNA, which eliminates centrifugation steps during pre-sequencing purification, reduces manipulation of extracted products and is suitable for automation, resides in a purification step which comprises the pressure activated separation of DNA or RNA from a digest suspension by ultrafiltration using a filter membrane which retains the nucleic acids and presents them in a state ready for immediate commencement of sequence determination in situ on the membrane. The filter membrane may retain nucleic acids by size exclusion and/or adsorb nucleic acids by surface binding.

Description


  
 



   A method of sequencing nucleic acids.



  The present invention relates to an improved method of sequencing nucleic acids, and particularly but not exclusively to an improved method of sequencing DNA.



  The technique of nucleotide sequence analysis is of central importance in molecular biology and biotechnology. Contemporary methods of sequencing are mostly based on the high resolving power of polyacrylamide-gel electrophoresis. By this technique two   oligonucleotides    which differ in size by only a single nucleotide residue can be resolved by virtue of their differing relative interactions with the gel matrix. Alternative resolving methods are currently being investigated, for example column based systems such as high pressure liquid chromatography (HPLC).



  In order to determine the sequence of nucleotides in a nucleic acid such as DNA a series of fragments are produced with one end in common and the other varying in position along the chain. A minimum of four types of series of fragments is produced, each group being terminated by or cleaved at one of the four possible bases by specific chemical or enzymic means.



  There are two well known ways in which DNA fragments ending in or cleaved at each of the four bases are produced for sequence analysis. In the method described by Maxam and Gilbert (reference 1 and 2) single- or double-stranded DNA molecules are labelled with radioactive 32P phosphate at a unique 5' or 3' terminus and the nucleotide chains are chemically   8modified    at specific bases and then cleaved by alkaline or piperidine hydrolysis. The chain termination method of Sanger et al (reference 3 to 6) involves enzymic copying of single-stranded DNA fragments using a DNA polymerase to transcribe specific regions of the chain under controlled conditions.  



  In both the above described methods it is necessary to extract and purify the nucleic acids prior to initiating sequencing reactions.



  Conventionally RNA and DNA from tissues, cells, plasmids and viruses are extracted and purified by lysis or digestion of the protein coat (e.g. with a protease - such as proteinase K - which is able to digest the protein coat without degrading the nucleic acids) followed by extraction with solvent, such as phenol-chloroform, and precipitation with e.g. ethanol. Separation of nucleic acids from suspension in solvents is achieved by repeated centrifugation.



  The phenol-chloroform reagent is a toxic corrosive liquid which is unpleasant to handle. After extraction with phenol-chloroform it is necessary to separate the aqueous from the organic phase.



  Centrifugation steps in the extraction/purification procedures are time consuming and tedious when carried out manually, and are difficult to automate satisfactorily.



  The present invention provides an improved method of sequencing nucleic acids, such as DNA, which eliminates centrifugation steps during pre-sequencing purification, reduces manipulation of extracted products and is suitable for automation.



  According to the invention, the improvement resides in a purification step which comprises the pressure activated separation of DNA or RNA from a digest suspension by ultrafiltration using a filter membrane which retains the nucleic acids and presents them in a state ready for immediate commencement of sequence determination in situ on the membrane.



  The filter membrane may (a) retain nucleic acids by size exclusion   andlor    may (b) adsorb nucleic acids by surface binding. Examples of filter membranes of type (a) are anisotropic low absorptive ultrafiltration membranes such as the type-YM membranes marketed by
Amicon Corporation (US Patent No. 3488768). Examples of filter  membranes of type (b) are nitrocellulose membranes,   NA45(Th),   
DE81(TM), Genescreen   (tri),      Hybond      (tri)    and the like; filter membranes having non-specific binding sites may be partially blocked with Bovine Serum Albumin   (BOA)    or other inert material.



  An advantage of using   nltrafiltration    for separation and purification of nucleic acids is that the material collected on the membrane can be further treated in situ. For example, chemical or enzymic reagents can be applied to the membrane surface after filtration in order to prepare the trapped nucleic acids for sequencing.



  The method of the invention can be used in an improved enzymic sequencing process including the following steps:   11    A vector carrying a DNA insert to be sequenced is cultured in a host, 2] vector particles containing the DNA inserts are separated from the host by filtration,   3 ]     a protease is applied which will digest the protein coat of the vector without degrading the DNA,   4 ]     the DNA is purified and concentrated by pressure activated ultrafiltration through a membrane which retains the DNA,   5 ]     primer is added and annealed to the extracted DNA on the membrane,   6 ]     a polymerisation enzyme together with a suitable nucleotide mixture is applied to the DNA on the membrane,

   the enzyme being one which is capable of catalysing the faithful incorporation of nucleotides onto a primed template,  7] chase nucleotides are added if necessary in order to complete the polymerisation reaction, 81 the reaction is terminated and the newly synthesized DNA is disassociated from the template, and 9] a sample of DNA is loaded onto a polyacrylamide gel for electrophoresis, or onto an alternative separation system.



  In the above described method any host/vector system can be used in which vector DNA is released from the host cell, generally in the form of a protein coated particle. The DNA could be single or double stranded; if the DNA is double stranded a denaturation step must be included before annealing in order to separate the strands.



  The chosen vector must have been manipulated so as to carry both the
DNA fragment to be sequenced and the appropriate primer hybridisation site. A particularly suitable host is the bacterium
E.Coli, and suitable vectors are bacteriophage M13, plasmid pEMBL and   F1    derived vectors.



   Examples of suitable protease are chymotrypsin, elastase, subtilisin and thermolysin. Residual protease activity can be terminated after the reaction has proceeded to completion by use of an ethanol wash or a protease inhibitor. Alternatively, the protease may have autolytic activity and hence be self-terminating. The catalysis enzyme is preferably a DNA polymerase such as a Klenow fragment of
DNA polymerase I or reverse transcriptase. The enzyme must not have exonuclease activity which would digest the primer; if present, exonuclease activity can be blocked by the addition of a blocking group at the 5' end of the molecule.



  If the above described method were adapted for sequencing with ribonucleotides, then ribonucleotides would be used instead of deoxyribonucleotides in the polymerisation step. In such a case an appropriate RNA polymerase would be used, possibly without the need  for a primer. Alternatively, if a suitable vector for RNA were developed, RNA could be used as the template.



  One embodiment of the invention will now be described in detail, by way of example only. The Example illustrates an improved method of
DNA sequencing using the chain termination method described by
Sanger.



  EXAMPLE
The method comprises the following steps 1) Bacteriophage M13 with a DNA insert is cultured overnight in
E.Coli in suitable culture medium.



  2) The bacteria are separated from the phage by filtration with a 0.22 micron membrane, such as hydrophilic Durapore (Millipore). The bacteria remain on the filter and the DNA-carrying phage pass through the membrane into a collection vessel.



  3) The phage are incubated with a protease, such as chymotrypsin, in order to digest the protein coat.



  4) The DNA from the phage is separated from the digested protein by pressure activated ultrafiltration through a membrane which retains the DNA but not the digested protein. A preferred sizeexclusion membrane is   YH10    (Amicon) which retains globular molecules of size greater than 10 kDaltons. Alternatively, an adsorptive membrane such as nitrocellulose may be used. Non-specific binding of reagents to the filter can be prevented by the addition of 1   Z    bovine serum albumin.



  5) The primer is added as a droplet or a spray to the DNA on the filter membrane and is annealed for 20 minutes at 55 to   65eC    to allow specific hybridisation.  



  6) Premixed nucleotides and DNA polymerase I Klenow fragment are added as a droplet or a spray to the filter membrane and are incubated at 200C for 15 minutes. The nucleotides are incorporated onto the primed template to synthesize DNA by chain extension. The nucleotides may include labelled nucleotides and chain terminating nucleotides.



  7) Chase nucleotides are added if necessary.



   8) A formamide droplet or spray is placed on the membrane and heated at 900C for 5 minutes in order to terminate reaction and caused disassociation of newly synthesized DNA from the template.



  9) A DNA sample is loaded onto a conventional polyacrylamide gela 10) The DNA fragments are separated by electrophoresis.



  REFERENCES 1. ' Maxam,   AM.    and Gilbert, W (1977), Proc.Natl. Acad.Sci., USA.,
 74, 560-564.



  2. Maxam, A.M. and Gilbert, W (1980), in Methods in Enzymology,
 (ed Wil, R), 68, p.499, Academic Press, London and New York.



  3. Sanger, F. and Coulson, A.R. (1978), FEBS lett.,87, 107-110.



  4. Sanger, F. and Coulson, A.R. (1975), J.Mol.Biol.,94, 441-448.



  5. Sanger, F., Nicklen, S. and Coulson, A.R. (1977),
 Proc.Natl.Acad.Sci., USA,74, 5463-5467.



  6. Air, G.M., Sanger, F. and Coulson, A.R. (1976),
   J.Mol.Biol. ,108,    519-533. 

Claims

CLAIMS:
1. An improved method of sequencing nucleic acids wherein the improvement resides in a purification step which comprises the pressure activated separation of DNA or RNA from a digest suspension by ultrafiltration using a filter membrane which retains the nucleic acids and presents them in a state ready for immediate commencement of sequence determination in situ on the membrane.
2. An improved enzymic sequencing process for DNA which includes the following steps i] a vector carrying a DNA insert to be sequenced is cultured in a host, ii] vector particles containing the DNA inserts are separated from the host by filtration, iii] a protease is applied which will digest the protein coat of the vector without degrading the DNA, iv] the DNA is purified and concentrated by pressure activated ultrafiltration through a membrane which retains the DNA, v ] primer is added and annealed to the extracted DNA on the membrane, vi] a polymerisation enzyme together with a suitable nucleotide mixture is applied to the DNA on the membrane, the enzyme being one which is capable of catalysing the faithful incorporation of nucleotides onto a primed template,
vii] chase nucleotides are added if necessary in order to complete the polymerisation reaction, viii] the reaction is terminated and the newly synthesized DNA is disassociated from the template, and ix) a sample of DNA is loaded onto a polyacrylamide gel for electrophoresis, or onto an alternative separation system.
3. An improved method of DNA Sequencing using the chain termination method of Sanger, which includes the following steps a) Bacterophage M13 with a DNA insert is cultured in E.Coli in suitable culture medium, b) the bacteria are separated from the phage by filtration with a hydrophilic membrane, c) the phage are incubated with chymotrypsin protease, d) the DNA from the phage is purified and concentrated by pressure activated ultrafiltration through a membrane which retains the DNA (e.g.
a size-exclusion membrane which retains globular molecules of size greater than 10 kDaltons or an adsorptive membrane such as nitrocellulose), e) primer is added as a droplet or a spray to the DNA on the filter membrane and is annealed for 20 minutes at 55 to 650C, f) premixed nucleotides and DNA polymerase I Klenow fragment are added as a droplet or a spray to the filter membrane and are incubated at 200C for 15 minutes, g) chase nucleotides are added if necessary, h) a formamide droplet or spray is placed on the membrane and heated at 900C for 5 minutes, i) a DNA sample is loaded onto a polyacrylamide gel, and j) DNA fragments are separated by electrophoresis.
4. An improved method of sequencing, substantially as hereinbefore described.
PCT/GB1987/000384 1986-06-04 1987-06-03 A method of sequencing nucleic acids WO1987007645A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868613476A GB8613476D0 (en) 1986-06-04 1986-06-04 Method of sequencing nucleic acids
GB8613476 1986-06-04

Publications (1)

Publication Number Publication Date
WO1987007645A1 true WO1987007645A1 (en) 1987-12-17

Family

ID=10598881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1987/000384 WO1987007645A1 (en) 1986-06-04 1987-06-03 A method of sequencing nucleic acids

Country Status (4)

Country Link
EP (1) EP0268647A1 (en)
JP (1) JPH01500482A (en)
GB (1) GB8613476D0 (en)
WO (1) WO1987007645A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009282A1 (en) * 1988-03-23 1989-10-05 Cemu Bioteknik Ab Method of sequencing dna
EP0340609A2 (en) * 1988-05-06 1989-11-08 F. Hoffmann-La Roche Ag Device for the isolation of nucleic acids
US5484701A (en) * 1990-01-26 1996-01-16 E. I. Du Pont De Nemours And Company Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
WO1998005673A1 (en) * 1996-08-01 1998-02-12 Megabios Corporation Methods for purifying nucleic acids
WO2000024927A1 (en) * 1997-10-23 2000-05-04 Qiagen Gesellschaft Mit Beschränkter Haftung Methods and means for isolating and purifying nucleic acids on surfaces
US6136555A (en) * 1993-07-09 2000-10-24 Cambridge Molecular Technologies Limited Purification method and apparatus
WO2000066723A1 (en) * 1999-05-04 2000-11-09 Millipore Corporation Method of ultrafiltration
WO2001019482A2 (en) 1999-09-17 2001-03-22 Millipore Corporation Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
EP0875271A3 (en) * 1991-12-02 2001-04-25 QIAGEN GmbH Process and apparatus for the isolation and purification of nucleic acids
WO2001094574A2 (en) * 2000-06-07 2001-12-13 Amersham Biosciences Corp Method and apparatus for purifying nucleic acids
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7129344B1 (en) 1998-11-17 2006-10-31 Whatman Bioscience Limited Nucleic acid isolation
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121778A1 (en) * 1983-03-12 1984-10-17 Hoechst Aktiengesellschaft Method for the separation of ribonucleic acids from a solution containing deoxyribonucleic acids
EP0127737A1 (en) * 1983-05-09 1984-12-12 Gambro Lundia AB A process for the recovery of a peptide-containing compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121778A1 (en) * 1983-03-12 1984-10-17 Hoechst Aktiengesellschaft Method for the separation of ribonucleic acids from a solution containing deoxyribonucleic acids
EP0127737A1 (en) * 1983-05-09 1984-12-12 Gambro Lundia AB A process for the recovery of a peptide-containing compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Volume 79, 15 October 1973, (Columbus, Ohio, US), C.W. HANCHER et al.: "Evaluation of Ultrafiltration Membranes with Biological Macromolecules", see page 165, Abstract 88983n, & Biotechnol. Bioeng. 1973, 15(4), 667-91 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405746A (en) * 1988-03-23 1995-04-11 Cemu Bioteknik Ab Method of sequencing DNA
WO1989009282A1 (en) * 1988-03-23 1989-10-05 Cemu Bioteknik Ab Method of sequencing dna
EP0340609A2 (en) * 1988-05-06 1989-11-08 F. Hoffmann-La Roche Ag Device for the isolation of nucleic acids
EP0340609A3 (en) * 1988-05-06 1991-07-31 F. Hoffmann-La Roche Ag Device for the isolation of nucleic acids
US5484701A (en) * 1990-01-26 1996-01-16 E. I. Du Pont De Nemours And Company Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
EP0875271A3 (en) * 1991-12-02 2001-04-25 QIAGEN GmbH Process and apparatus for the isolation and purification of nucleic acids
US6136555A (en) * 1993-07-09 2000-10-24 Cambridge Molecular Technologies Limited Purification method and apparatus
US8236495B2 (en) 1996-07-19 2012-08-07 Samuel Nochumson Process and equipment for plasmid purification
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US6011148A (en) * 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
WO1998005673A1 (en) * 1996-08-01 1998-02-12 Megabios Corporation Methods for purifying nucleic acids
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
WO2000024927A1 (en) * 1997-10-23 2000-05-04 Qiagen Gesellschaft Mit Beschränkter Haftung Methods and means for isolating and purifying nucleic acids on surfaces
EP2251440A3 (en) * 1997-10-23 2011-11-16 Qiagen GmbH Methods and means for isolating and purifying nucleic acids on surfaces
US7129344B1 (en) 1998-11-17 2006-10-31 Whatman Bioscience Limited Nucleic acid isolation
WO2000066723A1 (en) * 1999-05-04 2000-11-09 Millipore Corporation Method of ultrafiltration
US6645722B2 (en) 1999-09-17 2003-11-11 Millipore Corporation Method for sequencing reaction cleanup by constant differential pressure ultrafiltration
EP1218076A4 (en) * 1999-09-17 2005-03-30 Millipore Corp Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
WO2001019482A2 (en) 1999-09-17 2001-03-22 Millipore Corporation Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
US6498240B1 (en) 1999-09-17 2002-12-24 Millipore Corporation Method for sequencing reaction cleanup by constant pressure diffential ultrafiltration
EP1218076A2 (en) * 1999-09-17 2002-07-03 Millipore Corporation Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
EP2270207A3 (en) * 1999-09-17 2012-07-25 EMD Millipore Corporation Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
WO2001094574A3 (en) * 2000-06-07 2002-06-20 Amersham Biosciences Corp Method and apparatus for purifying nucleic acids
WO2001094574A2 (en) * 2000-06-07 2001-12-13 Amersham Biosciences Corp Method and apparatus for purifying nucleic acids

Also Published As

Publication number Publication date
JPH01500482A (en) 1989-02-23
EP0268647A1 (en) 1988-06-01
GB8613476D0 (en) 1986-07-09

Similar Documents

Publication Publication Date Title
EP1018549B1 (en) Method for isolating dna
US6383393B1 (en) Chromatographic purification and separation process for mixtures of nucleic acids
EP0442026B1 (en) Method to extract and purify human genomic DNA
US4446237A (en) Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
US5783686A (en) Method for purifying nucleic acids from heterogenous mixtures
US5484701A (en) Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
AU772213B2 (en) Biochemical purification devices with immobilized capture probes and their uses
WO1987007645A1 (en) A method of sequencing nucleic acids
CA2119140A1 (en) Dna cycle sequencing
DE19925862A1 (en) Process for the synthesis of DNA fragments
WO1994001447A1 (en) Methods of single nucleotide primer extension to detect specific alleles and kits therefor
EP0431905B1 (en) Method for purifying phage DNA
EP0979868B1 (en) Electrophoretic separation of nucleic acids from biological samples at low pH
WO2001062976A1 (en) Rapid nucleic acid separation, isolation and purification methods
EP1218076B1 (en) Method for sequencing reaction cleanup by constant pressure differential ultrafiltration
Brown Southern blotting and related DNA detection techniques
EP1144692B1 (en) Method for separating nucleic acids into populations
EP0647232B1 (en) Deproteinization with azlactone-functional supports
US20030228600A1 (en) DNA isolation method and kit
EP0278513B1 (en) Process of preparing single-stranded dna
Nichols DEOXYNUCLEOTIDE SEQUENCE ANALYSIS AROUND SITES CLEAVED IN VIVO BY ENDONUCLEASES INDUCED BY BACTERIOPHAGES T5, LAMBDA, PHI80, AND 21.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1987903715

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1987903715

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1987903715

Country of ref document: EP